Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OptimizeRx Corporation - Common Stock
(NQ:
OPRX
)
8.310
-0.250 (-2.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about OptimizeRx Corporation - Common Stock
< Previous
1
2
Next >
OptimizeRx Reports Second Quarter 2024 Financial Results
August 08, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program
From
OptimizeRx Corporation
Via
GlobeNewswire
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 20, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 16, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024
Market Embraces Disruptive AI-Powered Capabilities
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 04, 2024
Empowering healthcare providers to remove barriers to care
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
February 21, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 09, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 18, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Third Quarter 2023 Financial Results
November 06, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
October 25, 2023
Executive Leadership expands with Steve Silvestro being promoted to President, and Theresa Greco assuming the role of Chief Commercial Officer
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
October 12, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
September 26, 2023
The New AI-Directed Capability Unites Point-of-Care and Traditional Digital Medias to Provide a Comprehensive Solution for Pharmaceutical Marketing
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Expands AI Powered Omnichannel Platform
August 24, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Second Quarter 2023 Financial Results
August 14, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
July 31, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
May 24, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
May 18, 2023
Castagna was recognized as a Digital Crusader for her ongoing and leading-edge work in digital access to therapies for patients
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
May 15, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports First Quarter 2023 Financial Results
May 10, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
May 02, 2023
Physicians report that they are encountering brand information across multiple digital and in-person channels, yet still lack key information on patient eligibility, affordability, and access
From
OptimizeRx Corporation
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.